U.S. Markets closed

CombiMatrix Corporation (CBMX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
7.50+0.03 (+0.33%)
At close: 4:00PM EDT
People also watch
NANXACTGTINYFEICFLML
  • G
    Godwin
    Godwin

    Signup for the www.T0pm@rketgainers.c0m free newsletter, these guys have have been right on the money with all of their picks. They have a special trade alert coming out tomorrow at 9:30am EST. Their last 9:30 AM trade alert went up 64% in just one day. If you want to get an early jump on the fastest moving NASDAQ and OTC stocks signup now. Just google "pennystock101" Best of luck tomorrow.

  • N
    No Way Out
    No Way Out
    NVTA is bouncing around $10 per share, which makes the value of the pending merger swap worth between $8.40 and $9.00 per CBMX share - a nice arbitrage return that nobody seems interested in? There is always the risk that the NVTA share price will falter, but the recent earnings were solid and the acquisitions they announced will result in higher near-term growth, so there is as much chance that the NVTA shares advance from here.
  • h
    hrdwkgdog
    hrdwkgdog
    Money Street pumping this one today.................Anybody suspects something ?
  • S
    Sally
    Sally
    buy out just annouced
  • G
    GreatDayGuruStocks
    GreatDayGuruStocks
    Congrats on the buy out...
  • V
    Vicki
    Vicki

    Thanks for the tip, I did some research and found more information about $CBMX on http://jcharlesassets.com/heathlynked/?s=CBMX Making money day trading. "rht"

    Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
    We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
    jcharlesassets.com
  • G
    GreatDayGuruStocks
    GreatDayGuruStocks
    Watching to see if they break-even...
  • L
    Listener2307
    Listener2307
    Aegis Capital initiates coverage on CBMX. Price target of $8.10, and points out that even the lowest sales projections make it worth that much.

    Enterprise Value to Sales ratio for the group is 2.2; EV/Sales for Combimatrix is .8.
    On the verge of profitability.
    No further equity offerings should be required.
  • K
    Karen
    Karen
    In the short-term CBMX does not seem to be like a good trade. have you guys heard of awe.some.stock_s. i started receiving their allerts and so far i am happy.
  • p
    pernn
    pernn
    Beware of GreatDayIsBack2017. He's a boiler room scammer. Whatever scam stock he pumps, will implode.
  • n
    nice
    nice
    What's crapppppier CBMX or OMER or RAD? Too close to call?
  • b
    bohemain
    bohemain
    From $2,238.00 to $6.35. Is there a crappppppppppier stock?
    When do they close up shop? After another reverse split?
  • G
    GreatDayIsBack2017
    GreatDayIsBack2017
    Timber... Might buy at $5.20...
  • L
    Listener2307
    Listener2307
    Q2/ 2017 vs Q2/2016.
    Revenue in Q2/2016 was 3.107M. Looks like they'll do $4.0M in 2017 - that's a 30% increase which is what they have been doing for a while.
    But gross profit was 54% last year. They are running closer to 60% this year. That will make a big difference.
    They lost $1.24M last year. Running the figures for 2017, I see where they will lose $350K this year or roughly 12 cents/share.

    Anyone else got figures?
  • B
    Brian
    Brian
    Blowout!!! Beat by .07 and beat on revenues! This is finally going to return to above $10 where I will at least break even! Then I'll hold for profits. Very glad us long suffering longs are about to see vindication! Great job management!!!!!!!!!!!!
  • G
    GreatDayIsBack2017
    GreatDayIsBack2017
    Still trading at 36 cents before 15 to 1 Reverse Split... Quite the Volume today, 1 million shares traded with about 3 million shares outstanding...
  • P
    Pharmaheroooooo
    Pharmaheroooooo

    BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 2000%++ UPSIDE POTENTIAL !!!
    AQSZF (MC $11 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .

    Market Cap :US$ 11 Million
    Cash $4.1 Million << enough untill mid 2018
    Price 0.18

    MUST WATCH to realize the MONSTER POTENTIAL HERE
    https://www.youtube.com/watch?v=jV00WmYBtv4

    Presentation
    http://www.aequuspharma.ca/Investors/AQS%20investor%20November%202016_web.pdf

    Operational profitability estimated in 2017

    File for CDN approval of Topiramate XR in 1H 2017

    File for CDN approval of Oxcarbazepine XR in 1H 2017

    Additional Product Deals in 2017

    Partnership for AQS1301 in 2017

    Two products launches to date (Tacrolimus IR and Vistitan™)

    3 long-acting, transdermal programs in development, on track to file NDA in 2018

    Aequus Pharmaceuticals
    Aequus has an expanding product pipeline of drugs in Canada. Revenues and cash flows are increasing and products produce a 50% margin, Edward Karr, Managing ...
    www.youtube.com
  • D
    Dan
    Dan
    Where will this go tomorrow based on latest financial information?
  • G
    GreatDayIsBack2017
    GreatDayIsBack2017
    Debating to add a position here, local Orange County, CA investor... Albeit, CBMX has had about 3 Reverse Splits, so not a lot of confidence there... Is this the turning point with a loss under $500K vs. over $1.5 million last year... Cash Flow positive goal in Q4 2017???????? Only 2.9 million shares outstanding... Roll the dice here????????????????????
  • L
    Listener2307
    Listener2307
    Earning release May 4.
    I'm looking for $3.85M in revenue; $4.1 in total expenses for a loss of 250K. With 2.5M shares outstanding, that would be a loss of 10 cents per share.
    I would sure love to see more revenue, though, which of course would mean more of everything else but loss.